Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database.

Tomohito WakabayashiKeiko HosohataSaki OyamaAyaka InadaSayaka UenoHiroko KambaraTatsuya IidaTakahiro NakatsujiMayako UchidaKazunori Iwanaga

Published in: Therapeutics and clinical risk management (2020)

The strength of the associations of TNF-alfa inhibitors with adverse events is variable, and further studies are required to evaluate the identified signals.

Keyphrases

adverse drug
rheumatoid arthritis
replacement therapy
emergency department
smoking cessation